 Merck  Co agreed to buy Cubist Pharmaceuticals Inc for  billion as the drug giant pushes deeper into antibiotics an area seeing renewed interest because of the rise of dangerous new infections The deal which also includes the assumption of  billion in debt is worth  a share a  premium to Fridays close The Wall Street Journal and other media had reported on Friday that Merck was nearing a deal for Cubist worth about  a share